| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |